CLICK HERE FOR THE 2017 FINAL PROGRAMME & ABSTRACTS

2021 Programme Overview

THURSDAY 9 DECEMBER 2021

07:30                       Registration opens

10:00 – 10:05          Welcome and Introduction, J. Barker (London, UK), C. Griffiths (Manchester, UK)


Scientific Session 1

10:05 – 10:15              FC – 1

10:15 – 10:25              FC – 2

10:25 – 10:35              FC – 3

10:35 – 11:05              Invited Speaker: Driving discovery in psoriasis with human genetics M. Simpson (London, UK)

11:05 – 11:45              Coffee break

11:45 – 11:55              FC – 4

11:55 – 12:05              FC – 5

12:05 – 12:15              FC – 6

12:15 – 12:45              Invited Speaker: The Role of IL-36 in Psoriasis J. Gudjonsson (Ann Arbor, USA)

12:45 – 13:45              Lunch


Scientific Session 2

13:45 – 13:55              FC – 7

13:55 – 14:25              Invited Speaker: Animal models for Psoriasis N.Ward (Cleveland, USA) 

14:25 – 14:35              FC – 8

14:35 – 14:45              FC – 9

14:45 – 15:30              Keynote lecture: The Role of T-Regulatory Cells: Lessons from the Gut F. Powrie (Oxford, UK)

15:30 – 16:15              Tea break

16:15 – 16:45              Almirall Sponsored Lecture

16:50 – 17:20              UCB Pharma Sponsored Lecture

17:30 – 19:30              Welcome Reception, QEII Centre


FRIDAY 10 DECEMBER 2021


Scientific Session 3

08:00 – 08:30              AbbVie Sponsored Lecture

08:35 – 09:05              Janssen Sponsored Lecture

09:05 – 09:15              FC – 10

09:15 – 09:25              FC – 11

09:25 – 09:35              FC – 12

09:35 – 10:05              Invited Speaker: Addressing global unequal access to care W. Rehmus (Vancouver, Canada)

10:05 – 10:35              Coffee break

10:35 – 10:45              FC – 13

10:45 – 11:15              Invited Speaker: The Epidemiology of Psoriasis and the Global Psoriasis Atlas D. Ashcroft (Manchester, UK)

11:15 – 11:25              FC – 14

11:25 – 11:35              FC – 15

11:35 – 12:15              Keynote lecture: Improving human health through science F. Watt (London, UK)

 12:15 – 13:15             Lunch


Scientific Session 4

13:15 – 13:25              FC – 16

13:25 – 13:35              FC – 17

13:35 – 13:45              FC – 18

13:45 – 14:05              FC – 19

14:05 – 14:15              FC – 20

14:15 – 14:45              Invited Speaker: Innovation in clinical trials to transform practice M. Parmar (London, UK)

14:45 – 15:30              Tea break


Scientific Session 5

15:30 – 15:40              FC – 21

15:40 – 15:50              FC – 22

15:50 – 16:35              Keynote Lecture: Polygenic risk scores and disease progression and prevention P. Donnelly (Oxford, UK)

 16:35 – 17:05             Lilly Sponsored Lecture

17:10 – 17:40              Boehringer Ingelheim Sponsored Lecture

19:30 – 23:00              Congress Dinner


SATURDAY 11 DECEMBER 2021


Scientific Session 6

09:15 – 09:45             BMS Sponsored Lecture

09:45 – 09:55             FC – 23

09:55 – 10:05               FC – 24

10:05 – 10:15               FC – 25

10:15 – 10:45               Invited Speaker: Paradoxical reactions to biologics: mechanisms, features and management C. Conrad (Lausanne, Switzerland)

10:45 – 11:15               Coffee Break

11:15 – 11:25                FC – 26

11:25 – 11:35                FC – 27

11:35 – 12:05                Invited Speaker: Early intervention: rationale, strategies and measuring outcome L. Iversen (Aarhus, Denmark)

12:05 – 12:15                FC – 28

12:15 – 12:25                FC – 29

12:25 – 12:35                FC – 30

12:35 – 13:20                Keynote lecture: Progress in Unravelling the Complexities of Psoriasis Immunology J. Krueger (New York, USA)

13:20                              Presentation of poster prizes and close of Congress: J. Barker (London, UK), C. Griffiths (Manchester, UK)


Official Language

All congress sessions will be in English.